tiprankstipranks
Trending News
More News >
Evoke Pharma Inc (EVOK)
:EVOK
US Market

Evoke Pharma (EVOK) Technical Analysis

Compare
467 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
2Neutral
11Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Evoke Pharma Inc’s (EVOK) Moving Averages Convergence Divergence (MACD) indicator is -0.08, suggesting Evoke Pharma Inc is a Sell.
Evoke Pharma Inc’s (EVOK) 20-Day exponential moving average is 2.59, while Evoke Pharma Inc’s (EVOK) share price is $2.91, making it a Buy.
Evoke Pharma Inc’s (EVOK) 50-Day exponential moving average is 3.05, while Evoke Pharma Inc’s (EVOK) share price is $2.91, making it a Sell.

Evoke Pharma (EVOK) Pivot Points

May 02, 2025, 10:04 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.46
2.54
2.65
2.73
2.84
2.92
3.03
Fibonacci
2.54
2.62
2.66
2.73
2.81
2.85
2.92
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Evoke Pharma (EVOK) Moving Averages

May 02, 2025, 10:04 PM
Period
Simple
Exponential
MA5
2.71Buy
2.73Buy
MA10
2.56Buy
2.61Buy
MA20
2.38Buy
2.59Buy
MA50
3.16Sell
3.05Sell
MA100
3.90Sell
3.66Sell
MA200
4.49Sell
4.36Sell
Evoke Pharma Inc’s (EVOK) 10-Day exponential moving average is 2.61, while Evoke Pharma Inc’s (EVOK) share price is $2.91, making it a Buy.
Evoke Pharma Inc’s (EVOK) 100-Day exponential moving average is 3.66, while Evoke Pharma Inc’s (EVOK) share price is $2.91, making it a Sell.
Evoke Pharma Inc’s (EVOK) stock price is $2.91 and Evoke Pharma Inc’s (EVOK) 50-day simple moving average is 3.16, creating a Sell signal.
Evoke Pharma Inc’s (EVOK) stock price is $2.91 and Evoke Pharma Inc’s (EVOK) 100-day simple moving average is 3.90, creating a Sell signal.
Evoke Pharma Inc’s (EVOK) stock price is $2.91 and Evoke Pharma Inc’s (EVOK) 200-day simple moving average is 4.49, creating a Sell signal.

Evoke Pharma (EVOK) Technical Indicators

May 02, 2025, 10:04 PM
Name
Value
Implied Action
RSI (14)
58.63
Neutral
STOCH (9,6)
93.22
Sell
STOCHRSI (14)
94.07
Sell
MACD (12,26)
-0.08
Sell
ADX (14)
28.24
Neutral
Williams %R
-6.73
Sell
CCI (14)
188.24
Sell
ATR (14)
0.24
-
Ultimate Oscillator
76.00
Buy
ROC
29.91
Buy
Evoke Pharma Inc’s (EVOK) Relative Strength Index (RSI) is 58.63, creating a Neutral signal.
Evoke Pharma Inc’s (EVOK) Trend Strength Indicator (ADX) is 28.24, creating a Neutral signal.
Evoke Pharma Inc’s (EVOK) Commodity Channel Index (CCI) is 188.24, creating a Sell signal.
Evoke Pharma Inc’s (EVOK) Price Rate of Change (ROC) is 29.91, creating a Buy signal.

FAQ

Is EVOK a Buy, Hold, or Sell?
Based on EVOK’s technical indicators, EVOK is a Hold.
    What is EVOK’s RSI (14)?
    EVOK’s RSI (14) is 58.63, which suggests EVOK is a Neutral.
      What is EVOK’s MACD?
      EVOK’s MACD is -0.08, which suggests EVOK is a Sell.
        What is EVOK’s 5-day moving average?
        EVOK’s 5-day moving average is 2.71, which suggests EVOK is a Buy.
          What is EVOK’s 20-day moving average?
          EVOK 20-day moving average is 2.38, which suggests EVOK is a Buy.
            What is EVOK’s 50-day moving average?
            EVOK’s 50-day moving average is 3.16, which suggests EVOK is a Sell.
              What is EVOK’s 200-day moving average?
              EVOK’s 200-day moving average is 4.49, which suggests EVOK is a Sell.
                What is EVOK’s Williams % R (14)?
                EVOK’s Williams % R (14) is -6.73, which suggests EVOK is a Sell.
                  What is EVOK’s CCI (14)?
                  EVOK’s CCI (14) is 188.24, which suggests EVOK is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis